{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T20:13:24Z","timestamp":1695413604678},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00059-015-4218-2","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T14:28:14Z","timestamp":1427898494000},"page":"410-416","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Kardiovaskul\u00e4re Sch\u00e4den durch Doping"],"prefix":"10.1007","volume":"40","author":[{"given":"D.","family":"Thieme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"4218_CR1","unstructured":"Nationale Anti-Doping-Agentur (NADA) Deutschland (2015) Testpools und Risikogruppen. http:\/\/www.nada.de\/de\/doping-kontroll-system\/trainingskontrollen\/testpools\/#.VPhzcS54x3s, zugegriffen: 19.01.2015"},{"key":"4218_CR2","unstructured":"WADA (2015) List of Prohibited Substances and Methods. http:\/\/list.wada-ama.org\/, zugegriffen: 19.01.2015"},{"key":"4218_CR3","first-page":"A953","volume":"95","author":"Boos","year":"1998","unstructured":"Boos C, Wulff P, Kujath P, Bruch HP (1998) Medikamentenmi\u00dfbrauch beim Freizeitsportler im Fitne\u00dfbereich. Dtsch \u00c4rztebl 95:A953\u2013A957","journal-title":"Dtsch \u00c4rztebl"},{"key":"4218_CR4","first-page":"29","volume":"65","author":"Nie\u00df","year":"2014","unstructured":"Nie\u00df AM, Striegel H, Wiesing U (2014) Doping und Medikamentenmissbrauch im Breiten- und Freizeitsport. Dtsch Z Sportmed 65:29\u201333","journal-title":"Dtsch Z Sportmed"},{"key":"4218_CR5","unstructured":"Kistler L (2006) Todesf\u00e4lle bei Anabolikamissbrauch. Todesursache, Befunde und rechtsmedizinische Aspekte. LMU M\u00fcnchen"},{"key":"4218_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-3-540-79088-4_19","volume":"195","author":"B\u00fcttner","year":"2010","unstructured":"B\u00fcttner A, Thieme D (2010) Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. Handb Exp Pharmacol 195:459\u2013484","journal-title":"Handb Exp Pharmacol"},{"key":"4218_CR7","first-page":"618","volume":"31","author":"LaBree","year":"1991","unstructured":"LaBree M (1991) A review of anabolic steroids: uses and effects. J Sports Med 31:618\u2013626","journal-title":"J Sports Med"},{"key":"4218_CR8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644\u2013651","journal-title":"Med Sci Sports Exerc"},{"key":"4218_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02396586","volume":"59","author":"Fr\u00f6hlich","year":"1989","unstructured":"Fr\u00f6hlich J, Kullmer T, Urhausen A et al (1989) Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol Occup Physiol 59:98\u2013103","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"4218_CR10","first-page":"100","volume":"114","author":"Dodge","year":"2011","unstructured":"Dodge T, Hoagland MF (2011) The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug Alcohol Depend 114:100\u2013109","journal-title":"Drug Alcohol Depend"},{"key":"4218_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/beem.2000.0053","volume":"14","author":"Mottram","year":"2000","unstructured":"Mottram DR, George AJ (2000) Anabolic steroids. Baillieres Best Pract Res Clin Endocrinol Metab 14:55\u201369","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"4218_CR12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM200005183422018","volume":"342","author":"Arvary","year":"2000","unstructured":"Arvary D, Pope HG Jr (2000) Anabolic-androgenic steroids as a gateway to opioid dependence. N Engl J Med 342:1532","journal-title":"N Engl J Med"},{"key":"4218_CR13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.v64n0208","volume":"64","author":"Kanayama","year":"2003","unstructured":"Kanayama G, Cohane GH, Weiss RD, Pope HG (2003) Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry 64:156\u2013160","journal-title":"J Clin Psychiatry"},{"key":"4218_CR14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/1556-4029.12424","volume":"59","author":"Darke","year":"2014","unstructured":"Darke S, Torok M, Duflou J (2014) Sudden or unnatural deaths involving anabolic-androgenic steroids. J Forensic Sci 59:1025\u20131028","journal-title":"J Forensic Sci"},{"key":"4218_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5858\/2001-125-0253-ASAACS","volume":"125","author":"Fineschi","year":"2001","unstructured":"Fineschi V, Baroldi G, Monciotti F et al (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253\u2013255","journal-title":"Arch Pathol Lab Med"},{"key":"4218_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004140050165","volume":"111","author":"Hausmann","year":"1998","unstructured":"Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death \u2013 a case report and review of the literature. Int J Legal Med 111:261\u2013264","journal-title":"Int J Legal Med"},{"key":"4218_CR17","first-page":"33","volume":"6","author":"Madea","year":"1996","unstructured":"Madea B, Grellner W (1996) Langzeitfolgen und Todesf\u00e4lle bei Anabolikaabusus. Rechtsmedizin 6:33\u201338","journal-title":"Rechtsmedizin"},{"key":"4218_CR18","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.forsciint.2011.10.032","volume":"17","author":"Montisci","year":"2012","unstructured":"Montisci M, El Mazloum R, Cecchetto G et al (2012) Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 17:e13\u2013e18","journal-title":"Forensic Sci Int"},{"key":"4218_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1520\/JFS14635J","volume":"45","author":"Thiblin","year":"2000","unstructured":"Thiblin I, Lindquist O, Rajs J (2000) Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45:16\u201323","journal-title":"J Forensic Sci"},{"key":"4218_CR20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCHEARTFAILURE.109.931063","volume":"3","author":"Baggish","year":"2010","unstructured":"Baggish AL, Weiner RB, Kanayama G et al (2010) Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 3:472\u2013476","journal-title":"Circ Heart Fail"},{"key":"4218_CR21","unstructured":"Kindermann W, Urhausen A (2000) Pl\u00f6tzlicher Herztod beim Sport. Bundesinstitut f\u00fcr Sportwissenschaft, K\u00f6ln"},{"key":"4218_CR22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/00005768-199509000-00004","volume":"27","author":"Melchert","year":"1995","unstructured":"Melchert RB, Welder AA (1995) Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 27:1252\u20131262","journal-title":"Med Sci Sports Exerc"},{"key":"4218_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/hrt.2003.025783","volume":"90","author":"Payne","year":"2004","unstructured":"Payne JR, Kotwinski PJ, Montgomery HE (2004) Cardiac effects of anabolic steroids. Heart 90:473\u2013475","journal-title":"Heart"},{"key":"4218_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(00)01083-4","volume":"37","author":"Sader","year":"2001","unstructured":"Sader MA, Griffiths KA, McCredie RJ et al (2001) Androgenic-anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37:224\u2013230","journal-title":"J Am Coll Cardiol"},{"key":"4218_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","volume":"41","author":"Sullivan","year":"1998","unstructured":"Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1\u201315","journal-title":"Prog Cardiovasc Dis"},{"key":"4218_CR26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-2000-3835","volume":"21","author":"Tagarakis","year":"2000","unstructured":"Tagarakis CVM, Bloch W, Hartmann G et al (2000) Anabolic steroids impair the exercise-induced growth of the cardiac capillary bed. Int J Sports Med 21:412\u2013418","journal-title":"Int J Sports Med"},{"key":"4218_CR27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-540-79088-4_18","volume":"195","author":"Vanberg","year":"2010","unstructured":"Vanberg P, Atar D (2010) Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol 195:411\u2013457","journal-title":"Handb Exp Pharmacol"},{"key":"4218_CR28","first-page":"157","volume":"11","author":"Yesalis","year":"2001","unstructured":"Yesalis CE (2001) Use of steroids for self-enhancement: an epidemiologic\/societal perspective. AIDS Read 11:157\u2013160","journal-title":"AIDS Read"},{"key":"4218_CR29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.carpath.2011.10.002","volume":"21","author":"Far","year":"2012","unstructured":"Far HR, Agren G, Thiblin I (2012) Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings. Cardiovasc Pathol 21:312\u2013316","journal-title":"Cardiovasc Pathol"},{"key":"4218_CR30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/hrt.2003.015719","volume":"90","author":"Urhausen","year":"2004","unstructured":"Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90:496\u2013501","journal-title":"Heart"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-015-4218-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-015-4218-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-015-4218-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T02:20:16Z","timestamp":1651630816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-015-4218-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["4218"],"URL":"https:\/\/doi.org\/10.1007\/s00059-015-4218-2","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}